• Catalent Biologics, IVERIC bio Ink Mfg. Pact contractpharma
    June 18, 2019
    Paragon Gene Therapy, part of Catalent Biologics, will provide materials for preclinical and Phase 1/2 trials for IVERIC’s gene therapy product candidates.
PharmaSources Customer Service